Actionable news
0
All posts from Actionable news
Actionable news in ACOR: Acorda Therapeutics, Inc.,

Scopia Capital Management LP

Filed by: SCOPIA CAPITAL MANAGEMENT LP
Total Shares: 7,708,527
Subject Company: Acorda Therapeutics Inc - View Complete Ownership History Backtest
Filed as of Date: 08/07/2017
Event Date: 08/04/2017
Overall % Ownership: 16.5

Reporting Persons

Name Sole
Voting Power
Shared
Voting Power
Sole
Dispositive Power
Shared
Dispositive Power
Aggregate
Amount Owned
Percent
of class
Scopia Capital Management LP 0 7,708,527 0 7,708,527 7,708,527 16.5%
Scopia Management, Inc 0 7,708,527 0 7,708,527 7,708,527 16.5%
Matthew Sirovich 0 7,708,527 0 7,708,527 7,708,527 16.5%
Jeremy Mindich 0 7,708,527 0 7,708,527 7,708,527 16.5%

Raw Filing Contents

0001193125-17-249352.txt : 20170807

0001193125-17-249352.hdr.sgml : 20170807
20170807083057
ACCESSION NUMBER:		0001193125-17-249352
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20170807
DATE AS OF CHANGE:		20170807
GROUP MEMBERS:		JEREMY MINDICH
GROUP MEMBERS:		MATTHEW SIROVICH
GROUP MEMBERS:		SCOPIA MANAGEMENT, INC.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACORDA THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001008848
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-81801
		FILM NUMBER:		171010168

	BUSINESS ADDRESS:	
		STREET 1:		420 SAW MILL RIVER ROAD
		CITY:			ARDSLEY
		STATE:			NY
		ZIP:			10502
		BUSINESS PHONE:		914-347-4300

	MAIL ADDRESS:	
		STREET 1:		420 SAW MILL RIVER ROAD
		CITY:			ARDSLEY
		STATE:			NY
		ZIP:			10502

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SCOPIA CAPITAL MANAGEMENT LP
		CENTRAL INDEX KEY:			0001279150
		IRS NUMBER:				300711986
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		152 WEST 57TH STREET
		STREET 2:		33RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		212-370-0303

	MAIL ADDRESS:	
		STREET 1:		152 WEST 57TH STREET
		STREET 2:		33RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SCOPIA CAPITAL MANAGEMENT LLC
		DATE OF NAME CHANGE:	20130211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SCOPIA FUND MANAGEMENT LLC
		DATE OF NAME CHANGE:	20130116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SCOPIA FUND MANAGEMENT, LLC
		DATE OF NAME CHANGE:	20120410

SC 13D 1 d423672dsc13d.htm SCHEDULE 13D

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13D

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Acorda Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title and Class of Securities)

00484M106

(CUSIP Number)

Samantha Nasello

Scopia Capital Management LP

152 West 57th St., 33rd Floor

New York, NY 10019

(212) 370-0303

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

August 4, 2017

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. ☒

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)

Schedule 13D

(1)

Name of Reporting Persons:

Scopia Capital Management LP

(2)

Check the Appropriate Box if a Member of a Group (See Instructions):

(a) ☐ (b) ☐

(3)

SEC Use Only:

(4)

Source of Funds (See Instructions):

AF

(5)

Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e): ☐

(6)

Citizenship or Place of Organization:

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

(7)

Sole Voting Power

0

(8)

Shared Voting Power

7,708,527

(9)

Sole Dispositive Power

0

(10)

Shared Dispositive Power

7,708,527

(11)

Aggregate Amount Beneficially Owned by Each Reporting Person:

7,708,527

(12)

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): ☐

(13)

Percent of Class Represented by Amount in Row (11):

16.5%*

(14)

Type of Reporting Person (See Instructions):

PN, IA

* Based on 46,659,426 shares of Common Stock of Acorda Therapeutics, Inc. (the “Issuer”) outstanding as of April 30, 2017, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on May 9, 2017.

Schedule 13D

(1)

Name of...


More